Swedish 3D bioprinter provider CELLINK has released details of a partnership with French regenerative medicine research and development company CTI BIOTECH. A fully licensed human tissue biobank, CTI BIOTECH is using CELLINK 3D bioprinters to create tumorous tissue models in-lab, and investigate new therapies for patients with cancer. Professor Colin McGuckin, Founder of CTI BIOTECH, said, […]
from 3D Printing Industry
miércoles, 10 de enero de 2018
3:40
MR: EDITOR
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Related Posts